AOL Money & Finance

phillip morris posts

Feed

Altria (MO) falls on new legal precedent

MO logoAltria (NYSE: MO - option chain) stock is falling today after a Florida jury found that the death of a smoker was caused by his addiction to cigarettes. MO's subsidiary Philip Morris now is involved in the second phase of the trial , which is to decide who is at fault for his addiction. This is the first case in which an individual smoker's family sued a tobacco company for death by cigarette addiction. This is a tough precedent for MO and the cigarette industry, as it opens the industry up to potentially limitless civil suits from individual smokers.

While I believe that cigarette stocks are well-suited to our current environment, Phillip Morris International (NYSE: PM), a former subsidiary of MO, looks much more attractive to me, due in part to its lower exposure to the American legal system. PM is off by only 0.6% today compared to MO' s 3.5%. If you think Altria stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on MO.

Continue reading Altria (MO) falls on new legal precedent

Phillip Morris Int'l (PM) increases dividend

PM logoPhillip Morris International (NYSE: PM - option chain) shares are relatively flat today in the face of a bearish market as the company announced it will raise its regular quarterly dividend to 54 cents. As long as they pay that dividend quarterly, then this makes a tidy 4% yield.If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on PM that can take advantage of that dividend.

PM opened this morning at $53.76. So far today the stock has hit a low of $53.66 and a high of $54.46. As of 12:35, PM is trading at $53.96, up 4 cents(0.1%). The chart for PM looks bullish and S&P gives PM a positive 4 STARS (out of 5) buy ranking.

For a bullish hedged play on this stock, I would consider a March covered call at the $60 level. A covered call is an options position that combines the purchase of stock with the sale of call options to hedge risk in case the stock doesn't do what you think but still leverage nice returns. For this particular trade, we will make an 8.4% return in 7 months if PM is above $60 at March expiration. But unlike our normal credit spread trades, that is not the goal here. This position turns out strictly better than buying and holding the stock if it is below $61.25 at March expiration, and it makes a reasonable return in the unlikely event that the stock rises to that level. Plus, you can probably expect to catch at least two dividend payments over that time. We get about 2% of downside protection on this pretty stable stock by using a covered call. Learn more about this type of trade here.

PM has shown support just below $54 recently.

Brent Archer is an options analyst and writer at Investors Observer.

DISCLOSURE: Mr. Archer owns and/or controls diversified portfolios of long and short stock and option positions that may include holdings in companies he writes about. At publication time, Brent neither owns nor controls positions in PM.

Turnaround Kraft (KFT): New management 'shakes things up'

"With $37.2 billion in revenues in 2007, Kraft Foods (NYSE: KFT) is the largest food manufacturer in the U.S. and second-largest worldwide," notes leading turnaround stock expert George Putnam.

The editor of The Turnaround Letter explains, "New management has begun to shake things up and the turnaround program is well underway." Here's the advisor's review.

"The roots of some of Kraft's products reach all the way back to 1767, but it wasn't until 1903 that James L. Kraft started his wholesale cheese business from a horse drawn wagon in Chicago. Today, Kraft produces many of the best-known food brands in the world.

"In 1988, Philip Morris (renamed Altria) purchased Kraft, and in 2000 it integrated the purchase of Nabisco into Kraft. Altria sold a small stake to the public in 2001, but maintained majority control until 2007, when the company was completely spun off as an independent company once again.

"Under the Altria umbrella, Kraft stagnated, with declining revenues and little product innovation. As a result, the stock price today is within $1 of the price where it was when first sold to the public in mid-2001.

"New management has begun to shake things up at Kraft. In June 2006, veteran food executive Irene Rosenfeld became CEO, returning to Kraft from a stint at Pepsico running its Frito-Lay division.

Continue reading Turnaround Kraft (KFT): New management 'shakes things up'

Earnings highlights: Bank of America, Merck, Mattel, Phillip Morris, AFLAC and others

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Bank of America, Merck, Mattel, Phillip Morris, AFLAC and others

Option Update: Philip Morris volatility at 23 after spin-off from Altria Group

Philip Morris (NYSE: PM) closed at $50.60 Tuesday.

  • Altria Group (NYSE: MO) completed its spin-off of PM on March 31.
  • PM over all option implied volatility is at 23 according to Track Data.


Volatility Index S&P 500 Options-VIX at 22.36; 10-day moving average is 23.98

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Analyst initiations: WH, HRS and XTO

MOST NOTEWORTHY: WSP Holdings, Harris and XTO Energy were today's noteworthy initiations:

  • Oppenheimer believes WSP Holdings (NYSE: WH) is benefiting from rapid growth in the oil and gas exploration market and a move toward deeper and harsher environment drilling. The firm has an Outperform rating and $9.50 target on the stock.
  • UBS assumed Harris (NYSE: HRS) with a Buy rating and $63 target, as they see upside to the company's FY09 estimates driven by RF Communications. UBS views the recent pullback as a buying opportunity.
  • Morgan Keegan is positive on XTO Energy's (NYSE: XTO) projected 20% production growth, value building through acquisitions, and valuation; shares were initiated with an Outperform rating.

OTHER INITIATIONS:

Option Update: Philip Morris spun-off from Altria Group

Philip Morris (NYSE: PM) closed at $50.58.

Altria Group (NYSE: MO) completed its spin-off of PM on March 31.

Goldman has a 12-month price target of $60 on PM and says: "A premier tobacco company deserves a premium valuation."

PM overall option implied volatility is at 26 according to Track Data.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Altria's (MO) wisdom in spinning out Philip Morris International

The U.S. Supreme Court rejected Big Tobacco's appeal [subscription required] to throw out all of the remaining $145 billion class action against the major tobacco companies. Although the Florida Supreme Court had dismissed most of the case, 700,000 plaintiffs received the right to "use findings from the extensive jury trial to bring new cases against the tobacco companies," according to The Wall Street Journal. It gives the smokers and their families the ability to use old evidence in a new case.

A number of investors questioned the plan for Philip Morris parent, Altria (NYSE: MO) to spin-off its international tobacco operations. The overseas business is larger than the domestic one and is growing faster as smokers in areas like China become more inclined to use U.S. brands.

Part of the reasoning for the spin-off was to firewall Philip Morris International and its balance sheet from potential legal claims against the parent. It appeared that most of the class action suits against Big Tobacco were at an end, but the new legal decision shows that the assumption was not entirely true. The suits were based on the accusation that Big Tobacco knew the dangers of smoking but hid them from the public. That, in turn, caused millions of illnesses and deaths.

If the Florida decision is a set-back for Altria, the Philip Morris International business may have already left the building to pursue business overseas without the weight of decision in the U.S. legal system.

Douglas A. McIntyre is a partner at 24/7 Wall St.

Altria (MO) eyeing another spin-off, plus a trade idea

Altria Group MO logoAltria Group Inc. (NYSE: MO) is higher this morning as a Citigroup (NYSE: C) analyst stated this morning that she is 80-90% sure that sometime this week, Altria's board will approve spinning off Philip Morris International as a separate stock from Phillip Morris USA. MO spun-off Kraft Foods (NYSE: KFT) earlier this year to the delight of investors. If you think MO won't fall by too much in the coming months, now could be a good time to look at a bullish hedged trade.

MO stock has been relatively flat for the better part of a year, with resistance in the low $70's. This morning, MO opened at $70.00. So far today the stock has hit a low of $69.69 and a high of $70.99. As of 10:40, MO is trading at $70.63, up $1.44 (2.1%). The chart for Altria looks bearish and steady, while S&P gives the stock its highest 5 STARS (out of 5) strong buy rating.

For a bullish hedged play on this stock, I would consider a December bull-put credit spread below the $60 range. A bull-put credit spread is an options position that combines the purchase and sale of put options to hedge risk in case the stock doesn't do what you think but still leverage nice returns. For this particular trade, we will make a 6.4% return in just 4 months as long as MO is above $60 at December expiration. Altria would have to fall by more than 15% before we would start to lose money.

MO hasn't been below $60 since October and has shown support around $67 recently. This trade could be risky if anti-tobacco litigation picks up in the coming months, but even if that happens, this trade could be protected by the strong support between $63 and $65.

Brent Archer is an options analyst and writer at Investors Observer.

DISCLOSURE: At publication time, Brent owns and controls a bullish hedged position in MO.

Altria (MO): 'A company in transition'

"Altria Group (NYSE: MO) is a company in transition, catching its breath after spinning off giant Kraft Foods, restructuring North American production facilities, and preparing to sell Philip Morris International," notes Tom Slee.

The contributing analyst with Internet Wealth Builder has reaffirmed his buy rating, noting "Analysts expect an announcement in the next month or so about the divestiture, as well as plans for a major stock repurchase program."

He adds, "Not that Altria is resting on its laurels, however. The world's largest tobacco company is test marketing a smokeless tobacco in order to combat smoking bans."

The product, he points out, called Marlboro Snus, is a small pouch of dried tobacco that users place in the mouth. Unlike chewing tobacco, however, Snus do not require spitting.

He states, "Because of the health hazards and resulting litigation, tobacco remains a controversial industry. However, if you can put that aside, the fundamentals for leading producers such as Altria remain good.

Slee adds, "While Europeans and North Americans have been abandoning the habit, it's estimated that there are now more than 300 million male smokers in China, equal to about the entire U.S. population. Whether we like smoking or not, the fact is that Altria is extremely well positioned to benefit from what remains a growth industry."

Altria, like most stocks, has taken a beating, he observes. But, he adds, "The stock is now trading at 15.9 times this year's expected earnings of $4.25 and yielding 4.1% on a $2.76 dividend. This provides the stock with downside protection."

Each day, Steven Halpern's TheStockAdvisors.com features the latest investment ideas and market commentary from the financial newsletter community.

Altria Group (MO): A 5-year buy-and-hold

While many advisors buy and sell based on the outlook for the next few weeks or months, the legendary advisor Charles Allmon takes a decidedly long-term approach to investing. Indeed, the editor of Growth Stock Outlook is recommending a buy on Altria Group (NYSE: MO) for those looking to buy and hold a stock for the next five years.

Allmon, featured in The Bull & Bear Financial Digest, explains, "Altria, and its Phillip Morris operation, hardly needs introduction as the world's largest tobacco company. Marlboro, their famous and leading brand, continues to grow, particularly in international markets. Revenues in 2007 might approach $70 billion, after the Kraft spin-off."

He continues, "Altria's foreign cigarette business in recent years has grown nicely, well ahead of Phillip Morris USA. This could continue for the foreseeable future, even though foreign brands continue to offer stiff competition." Allmon adds, "Do keep in mind that Altria pays a hefty cash dividend which has been raised substantially each year."

He also speculates, that there is the prospect that Altria will split into two companies, Phillip Morris USA and Phillip Morris International. In that event he says, "I would expect to hold shares of both, which most likely will continue to lay those golden eggs - cash!" His conclusion? "I would buy MO today for a five-year hold."

Each day, Steven Halpern's TheStockAdvisors.com features the latest investment ideas and market commentary from the financial newsletter community.

Tobacco to fall under FDA control?

The Family Smoking Prevention and Tobacco Control Act, to be voted on today by the Senate Health Committee, seems on the fast track to approval. If passed into law it will place the tobacco industry under the oversight of the Food and Drug Administration. The measure, supported by health groups and some of the industry, will give the agency some broad powers in regulating the contents and sales of tobacco products.

Industry heavyweight Altria Group's (NYSE: MO) Phillip Morris favors the bill, but others such as Reynolds American's (NYSE: RAI) R.J. Reynolds oppose it, claiming the regulations would limit its ability to compete with the market leader.

Continue reading Tobacco to fall under FDA control?

Altria earnings disappoint as U.S. business weakens

Shares of Altria Group, Inc. (NYSE: MO) fell today after the cigarette maker disappointed Wall Street, missing analysts' expectations and cutting its earnings guidance for the year to $4.05 to $4.10 per share down from April's $4.20 to $4.25 level.

Earnings per share were $1.05, down from $1.29 last year and under the $1.13 of First Call estimates. Revenues grew almost 10% year-over-year to $18.8 billion, the company said. Bloomberg News notes that the U.S. business is declining at a faster rate than analysts expected.

Simultaneously, the company is acquiring a 30% stake in a Mexican tobacco business from Grupo Carso. CFO Dinyar S. Devitre noted that the international businesses are ready to be split up, although no timing has been given. And who said smoking is a dead-end business? Altria shares are actually up since the company completed its Kraft Foods (NYSE: KFT) spin-off, and shareholders still have the likely spin-off of Phillip Morris International coming down the pipe.

Many investors would have thought the company's future was in the ashtray, but the company has defied the skeptics, even though everyone knows that its products kill. Actually, shares are up considerably over the last 10-years and it has paid significant dividends. Even the states don't want the company to entirely disappear because cigarettes are responsible for generating huge amounts of tax revenue.

Investors may not all be tobacco fans, but they probably all will say "Keep Smoking!, thanks for the money."

Jon Ogg is a partner at 24/7 Wall St.; he does not own securities in the companies he covers.

Merck's Vioxx strategy starts to look more risky

Merck & Co., Inc. (NYSE:MRK) made the decision to litigate any claims that consumers have about the side effects of it drug Vioxx. There were studies that indicated that the drug could cause heart attacks in some patients.

Merck is facing 27,000 lawsuits from patients who posit that Vioxx caused them health problems. The company has decided to try the cases instead of attempting to enter into one large settlement covering all claims. Not unlike Altria Group, Inc.'s (NYSE:MO) Philip Morris and its tobacco litigation, Merck knows that the cost of bringing suit against it is substantial, so if the company wins a number of early cases, other plaintiffs may back off.

A jury in New Jersey has now found that Merck did recklessly promote the drug and awarded a patient $47.5 million. Merck will obviously appeal the case.

The brilliance of Merck's move to try cases with the goal of wearing down Vioxx claims may be the company's downfall. A raft of "wins" against the company could drive its liability into the billion of dollars. At that point, the company's future could be at stake.

Douglas A. McIntyre is a partner at 24/7 Wall St.

Daily option update - January 31, 2007

Note: The Daily Option Update is provided by Options Specialist Paul Foster of theflyonthewall.com.

Volatility Index S&P 500 Options-VIX down .47 to 10.49 after FOMC leaves rates unchanged at 5.25%

Comcast Corp. -(NASDAQ:CMCSK) option prices reveal subtle risks as expected into 2/1 EPS. Comcast will report EPS before the open on 2/1. Comcast February 45 straddle is priced at $2.30, above its theoretical value of $1.96 according to Track Data, suggesting increasing near term price fluctuations risks into EPS.

Google Inc.-(NASDAQ:GOOG )February option implied volatility elevated as expected into EPS. Google will report EPS after the close tonight. American Technology says "expect a solid report after close; Flat stock may reflect lower expectations." Google call option volume of 84,845 contracts compares to put volume of 54,692 contracts. Google February option implied volatility of 45 is above its 26-week average of 34 according to Track Data, suggesting larger price risks.

Option volume leaders today were: Altria Group Inc. (NYSE: MO), SanDisk Corp. (NASDAQ:SNDK), Citigroup (NYSE:C), Bristol Myers Squibb (NYSE:BMY) and Microsoft Corp.(NASDAQ:MSFT).

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA+203.5210,226.94
NASDAQ+41.622,154.06
S&P 500+23.781,093.08

Last updated: November 10, 2009: 06:10 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance